Picture of Alivus Life Sciences logo

ALIVUS — Alivus Life Sciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Brief: Glenmark Life Sciences Expects GPL Business To Remain Steady In Coming Quarters

April 27 (Reuters) - Glenmark Life Sciences Ltd
 GLEM.NS :
    * EXPECT GPL BUSINESS TO REMAIN STEADY IN COMING QUARTERS
    * EXTERNAL BUSINESS WAS DRIVEN BY STRONG GROWTH IN US,
LATAM, AND
JAPAN

Source text for Eikon:  ID:nBSE3HCg6x 
Further company coverage:  GLEM.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Alivus Life Sciences

See all news